购物车
- 全部删除
- 您的购物车当前为空
LJ-2698作为一种腺苷A3受体拮抗剂,目前正在研究用于治疗肺气肿和DKD(Diabetic Kidney Disease)。在小鼠肺模型中,LJ-2698能有效减轻由弹性蛋白酶引起的负面影响,同时抑制基质金属蛋白酶的活性和细胞凋亡。此外,LJ-2698在治疗糖尿病肾病方面的应用也得到了探索,已在小鼠中成功预防了多种类型的肾损伤。
LJ-2698作为一种腺苷A3受体拮抗剂,目前正在研究用于治疗肺气肿和DKD(Diabetic Kidney Disease)。在小鼠肺模型中,LJ-2698能有效减轻由弹性蛋白酶引起的负面影响,同时抑制基质金属蛋白酶的活性和细胞凋亡。此外,LJ-2698在治疗糖尿病肾病方面的应用也得到了探索,已在小鼠中成功预防了多种类型的肾损伤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | LJ-2698 is an adenosine A3 receptor antagonist under investigation for treating emphysema and DKD (Diabetic Kidney Disease). In mouse lung models, LJ-2698 effectively mitigates elastase-induced adverse effects and inhibits matrix metalloproteinase activity and apoptosis. Additionally, it is being explored for its potential in treating diabetic nephropathy, successfully preventing various types of kidney damage in mice. |
别名 | LJ2698, LJ 2698 |
分子量 | 412.29 |
分子式 | C16H15Cl2N5O2S |
CAS No. | 945457-84-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容